Analyst Ratings for Ovid Therapeutics Inc (OVID)
OVID Rating Summary
OVID Price Target Summary
- Highest: $11.00 (BTIG)
- Lowest: $4.00 (Citi)
- Average: $7.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.80 (+143%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 69%
Avg. $ Target:
$7.80 (+143%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/5/2024 | Wedbush | Laura Chico | New Coverage | Outperform (N/A) |
8.00 (N/A) |
3.05 (3.21) |
5.25% | Details |
| 12/21/2023 | BTIG | Thomas Shrader | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.54 (3.21) |
-9.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
